Related references
Note: Only part of the references are listed.Dysregulation of Cholesterol Homeostasis in Human Prostate Cancer through Loss of ABCA1
Byron H. Lee et al.
CANCER RESEARCH (2013)
Anticancer Activity of the Cholesterol Exporter ABCA1 Gene
Bradley Smith et al.
CELL REPORTS (2012)
Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer
Kun-Tu Yeh et al.
EPIGENETICS (2011)
Anticancer Efficacy of Simvastatin on Prostate Cancer Cells and Tumor Xenografts Is Associated with Inhibition of Akt and Reduced Prostate-Specific Antigen Expression
Samith T. Kochuparambil et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Kristin M. Nieman et al.
NATURE MEDICINE (2011)
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
Anna Martirosyan et al.
BMC CANCER (2010)
Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers
Andrew J. Li et al.
GYNECOLOGIC ONCOLOGY (2010)
Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein
Daniel R. Scoles et al.
GYNECOLOGIC ONCOLOGY (2010)
TGF-beta 1 Up-Regulates Expression of ABCA1, ABCG1 and SR-BI through Liver X Receptor a Signaling Pathway in THP-1 Macrophage-Derived Foam Cells
Yan-Wei Hu et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Combined Inhibitory Effects of Celecoxib and Fluvastatin on the Growth of Human Hepatocellular Carcinoma Xenografts in Nude Mice
J. Gao et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
Jian-Liang Chou et al.
LABORATORY INVESTIGATION (2010)
An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules
Huaxia Qin et al.
BMC SYSTEMS BIOLOGY (2009)
Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression
Hongli Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Epigenetics and cancer without genomic instability
Elizabeth S. McKenna et al.
CELL CYCLE (2009)
Characterization of LMX-1A as a metastasis suppressor in cervical cancer
Chin-Yu Liu et al.
JOURNAL OF PATHOLOGY (2009)
The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
Vladimir Nossov et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Impact of statin therapy on survival in epithelial ovarian cancer
R. Geoffrey Elmore et al.
GYNECOLOGIC ONCOLOGY (2008)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Role of endocrine and growth factors on the ovarian surface epithelium
Alice S. T. Wong et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2007)
Biochemical changes in tumor tissues of oral cancer patients
K Kolanjiappan et al.
CLINICAL BIOCHEMISTRY (2003)
Autoregulation of the human liver X receptor α promoter
BA Laffitte et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1
PE Fielding et al.
BIOCHEMISTRY (2000)